Lee Jiseok, Kim Bo-Ram, Park Kyeoungtae, Kim Eunbin, Jeong Jin-Woo, Kim Jung Jin, Suh Sung-Suk, Seo Jong Bae
Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam, Republic of Korea.
Division of Natural Products Research, Honam National Institute of Biological Resource, Mokpo, Republic of Korea.
Anim Cells Syst (Seoul). 2025 Jul 25;29(1):469-487. doi: 10.1080/19768354.2025.2536022. eCollection 2025.
(ZS), which is widely used as a seasoning and traditional medicine in East Asia, has demonstrated pharmacological potential. This study investigated the effects of the leaf and twig extracts of ZS (LZSE and TZSE, respectively), which are native to the Honam region of Korea, on adipocyte differentiation and assessed the ligand-binding energy score of their components to bind peroxisome proliferator-activated receptor gamma (PPARγ), a critical regulator of adipogenesis and metabolic health. LZSE and TZSE were prepared using 70% ethanol, and their molecular effects on adipocyte differentiation were evaluated in 3T3-L1 preadipocytes. Single compounds from the extracts were identified using UPLC-ESI-Q-TOF-MS, and their ligand-binding energy scores were calculated via in silico molecular docking studies. PPARγ activity was further confirmed through reporter assays. LZSE and TZSE significantly promoted adipocyte differentiation, as demonstrated by morphological changes and the increased mRNA and protein levels of key adipogenic and lipogenic genes, such as PPARγ and CCAAT-enhancer-binding protein alpha (C/EBPα). LZSE specifically enhanced adipogenesis without inducing cytotoxicity, attributed to the inhibition of C/EBP homologous protein (CHOP) and stimulation of mitotic expansion. Additionally, UPLC-ESI-Q-TOF-MS identified several active compounds in LZSE and TZSE, and in silico docking revealed the high binding affinity of these compounds for the full-agonist ligand-binding domain of PPARγ. LZSE and TZSE could emerge as novel antidiabetic drug candidates based on their effects on adipocyte differentiation and PPARγ activation. Furthermore, the active compounds identified in these extracts hold promise as tentative PPARγ agonists, highlighting their therapeutic potential in the treatment of metabolic disorders.
紫苏(ZS)在东亚地区广泛用作调味料和传统药物,已显示出药理潜力。本研究调查了原产于韩国湖南地区的紫苏叶提取物(LZSE)和紫苏枝提取物(TZSE)对脂肪细胞分化的影响,并评估了其成分与过氧化物酶体增殖物激活受体γ(PPARγ)结合的配体结合能得分,PPARγ是脂肪生成和代谢健康的关键调节因子。使用70%乙醇制备LZSE和TZSE,并在3T3-L1前脂肪细胞中评估它们对脂肪细胞分化的分子作用。通过超高效液相色谱-电喷雾电离-四极杆-飞行时间质谱(UPLC-ESI-Q-TOF-MS)鉴定提取物中的单一化合物,并通过计算机辅助分子对接研究计算它们的配体结合能得分。通过报告基因检测进一步证实PPARγ活性。形态学变化以及关键脂肪生成和脂质生成基因(如PPARγ和CCAAT增强子结合蛋白α(C/EBPα))的mRNA和蛋白质水平增加表明,LZSE和TZSE显著促进脂肪细胞分化。LZSE特异性增强脂肪生成而不诱导细胞毒性,这归因于对C/EBP同源蛋白(CHOP)的抑制和有丝分裂扩增的刺激。此外,UPLC-ESI-Q-TOF-MS鉴定出LZSE和TZSE中的几种活性化合物,计算机辅助对接显示这些化合物对PPARγ的全激动剂配体结合域具有高结合亲和力。基于LZSE和TZSE对脂肪细胞分化和PPARγ激活的作用,它们可能成为新型抗糖尿病药物候选物。此外,在这些提取物中鉴定出的活性化合物有望作为暂定的PPARγ激动剂,突出了它们在治疗代谢紊乱方面的治疗潜力。